Initial clinical trial of a selective retinoid X receptor ligand, LGD1069

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 790-795

  Miller, V A ^a   Benedetti, F M ^a   Rigas, J R ^a   Verret, A L ^a   Pfister, D G ^a   Straus, D ^a   Kris, M G ^a   Crisp, M ^a   Heyman, R ^a   Loewen, G R ^a   Truglia, J A ^a   Warrell Jr , R P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; RETINOID X RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; CANCER CHEMOTHERAPY; CHEILITIS; CLINICAL TRIAL; DOSE CALCULATION; FEMALE; HEADACHE; HUMAN; HYPERCALCEMIA; HYPERTRIGLYCERIDEMIA; LEUKOPENIA; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSCRIPTION REGULATION;

EID: 0031024325     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.790     Document Type: Article

References (29)

1. Chytil F: Retinoic acid: Biochemistry, pharmacology, toxicology, and therapeutic use. Pharmacol Rev 36:93S-100S, 1984
2. Lippman S, Batsakis J, Toth B, et al.: Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328:15-20, 1993
3. Lippman SM, Parkinson DR, Itri LM, et al.: 13-cis-Retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235-241, 1992
4. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al.: 13-cis-Retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241-245, 1992
5. Warrell RP, Jr., de The H, Wang ZY, et al.: Acute promyelocytic leukemia. N Engl J Med 329:177-189, 1993
6. Miller WH Jr, Jakubowski A, Tong WP, et al.: 9-cis Retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021-3027, 1995
7. Mangelsdorf DJ: Vitamin A receptors. Nutr Rev 52:S32-S44, 1994
8. Borrow J, Goddard AD, Sheer D, et al.: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577-1580, 1990
9. de The J, Chomienne C, Lannote M, et al.: The t(15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558-561, 1990
10. Mangelsdorf DJ, Ong ES, Dyck JA, et al.: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229, 1990
11. Keller H, Dreyer C, Medin J, et al.: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90:2160-2164, 1993
12. Zhang XK, Hoffman B, Tran PBV, et al.: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446, 1992
13. 3 signalling. Nature 355:446-449, 1992
14. Heyman RA, Mangelsdorf DJ, Dyck JA, et al.: 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406, 1992
15. Levin AA, Sturzenbecker LJ, Kazmer S, et al.: 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXR α. Nature 355:359-361, 1992
16. Miller VA, Rigas JR, Benedetti FM, et al.: Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 2:471-475, 1996
17. Mehta K, McQueen T, Neamati N, et al.: Activation of retinoid receptors RAR- a and RXR- a induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ 7:179-186, 1996
18. Nagy L, Thomazy VA, Shipley GL, et al.: Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3540-3551, 1995
19. Heinzel G, Woloszczak R, Thomann P: Topfit 2.0 Pharmacokinetic and Pharmacodynamic Data Analysis for the PC. Gustav Fischer, 1993
20. Gibaldi M, Perrier D: Pharmacokinetics (ed 2). New York, NY, Marcel Dekker, 1982
21. Miller VA, Rigas JR, Muindi JRF, et al.: Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol 34:522-526, 1994
22. Lee JS, Newman RA, Lippman SM, et al.: Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Oncol 11:959-966, 1993
23. Krust A, Kastner P, Petkovich M, et al.: A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 86:5310-5314, 1989
24. Zelent A, Krust A, Petkovich M, et al.: Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin. Nature 339:714-717, 1989
25. Bershad S, Rubinstein A, Paterniti JR Jr, et al.: Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 16:981-985, 1985
26. Rigas JR, Miller VA, Levine DM, et al.: Lipoprotein alterations in patients treated with novel retinoids. Proc Am Assoc Cancer Res 36:506, 1995 (abstr)
27. Hallenbeck PL, Marks MS, Lippoldt RE, et al.: Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR β) enhances DNA binding and TH-dependent transcriptional activation. Proc Natl Acad Sci USA 89:5572-5576, 1992
28. Lee IJ, Driggers PH, Medin JA, et al.: Recombinant thyroid hormone receptor and retinoid X receptor stimulate ligand-dependent transcription in vitro. Proc Natl Acad Sci USA 91:1647-1651, 1994
29. Muindi JRF, Frankel SR, Huselton C, et al.: Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138-2142, 1992